Article
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease.
Frontiers in immunology - 1 Jan 2021
Ren Pingping, Lu Luying, Cai Shasha, Chen Jianghua, Lin Weiqiang, Han Fei
Abstract excerpt
Alternative splicing (AS) is a complex coordinated transcriptional regulatory mechanism. It affects nearly 95% of all protein-coding genes and occurs in nearly all human organs. Aberrant alternative splicing can lead to various neurological diseases and cancers and is responsible for aging, infection, inflammation, immune and metabolic disorders, and so on. Though aberrant alternative splicing events and their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
